Xencor reported $695.6M in Assets for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Alexion Pharmaceuticals ALXN:US $ 18650.2M 547.2M
Alnylam Pharmaceuticals ALNY:US $ 3509.43M 254.16M
Amgen AMGN:US $ 59773M 2766M
Arrowhead Research ARWR:US $ 734.93M 21.87M
AstraZeneca AZN:LN 73641M 8715M
Biogen BIIB:US $ 24470.4M 615.7M
Bristol Myers Squibb BMY:US $ 110797M 1638M
Cytokinetics CYTK:US $ 564.3M 12.76M
Epizyme EPZM:US $ 352.55M 54.16M
GlaxoSmithKline GSK:LN 77011M 1068M
Karyopharm Therapeutics KPTI:US $ 286.57M 11.66M
Macrogenics MGNX:US $ 425.91M 9.53M
Novartis NOVN:VX SF 124015M 2263M
Regeneron Pharmaceuticals REGN:US $ 21485.9M 3713.7M
Seattle Genetics SGEN:US $ 3952.16M 9.17M
Xencor XNCR:US $ 695.6M 2.86M